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Kawasaki	disease	(KD)	is	an	acute	febrile	vasculitis	of	un-
known	etiology	that	predominantly	affects	children	younger	
than	5	years.
1)2)	Because	KD	causes	systemic	vasculitis,	multi-
ple	organ	involvement	may	ensue,	including	coronary	artery	le-
sions	(CALs),	carditis,	arthritis,	hepatitis,	central	nervous	sys-
tem	disease,	kidney	and	urinary	tract	abnormalities,	muscle	
involvement	and	hyponatremia.
2)3)		Nakamura	et	al.
4)	also	re-
cently	reported	that	hyponatremia	at	the	patient’s	first	visit	to	
hospital	might	be	a	predictor	of	giant	coronary	aneurysm	(>8	
mm),	and	speculated	that	the	relationship	between	hypona-
tremia	and	giant	coronary	aneurysms	is	based	on	endothelial	
permeability,	severity	of	the	illness,	dehydration,	duration	of	
febrile	period.	Although	hyponatremia	is	not	uncommon	in	
patients	with	KD,
3)	the	clinical	characteristics	of	KD	patients	
with	hyponatremia	remain	inadequately	understood.	Patients	
with	hyponatremia	may	exhibit	more	severe	inflammatory	
findings,	including	longer	duration	of	fever,	higher	C-reactive	
protein	(CRP)	concentrations	and	alanine	aminotransferase	
levels	and	increased	incidence	of	CAL,	than	in	patients	with-
out	hyponatremia.
5)	Lim	et	al.
6)	also	reported	that	serum	sodi-
um	was	inversely	correlated	with	neutrophil,	CRP,	and	N-ter-
minal	pro-B-type	natriuretic	peptide,	and	speculated	that	hy-
ponatremia	occurs	in	KD	patients	with	more	severe	inflamm-
ation.	
Although	the	pathogenesis	of	hyponatremia	in	KD	remains	
inadequately	understood,	several	possible	mechanisms	have	
been	postulated,	including	the	syndrome	of	inappropriate	an-
tidiuretic	hormone	secretion	(SIADH),	hyponatremic	dehy-
dration	and	ingestion	of	fluid	that	is	hypo-osmolar	relative	
to	the	fluid	lost.
3)	Recently,	the	relationship	between	interleu-
kin	(IL)-6	or	IL-1	beta	and	ADH	secretion	has	been	suggest-
ed.
7)8)	Mastorakos	et	al.
7)	reported	that	plasma	ADH	levels	
were	elevated	after	IL-6	injection	in	cancer	patients,	suggest-
ing	that	IL-6	activated	the	magnocellular	ADH-secreting	
neurons,	and	that	it	might	be	involved	in	SIADH.	Ohta	and	
Ito
8)	reported	four	cases	with	hyponatremia	secondary	to	SI-
ADH,	which	seems	to	be	related	to	inflammation.	Plasma	Na
+	
concentrations	decreased	and	plasma	CRP	level	increased	
when	the	patients	had	fever.	In	such	conditions,	plasma	ADH	
and	IL-6	concentrations	were	increased	and	there	was	signif-
icant	correlation	between	them.	Intravenous	administrations	
of	IL-1	beta	increased	ADH,	atrial	natriuretic	hormone,	and	
adrenocorticotropic	hormone	(ACTH).	The	changes	in	ADH	
and	ACTH	were	abolished	by	pretreatment	administration	
of	intravenous	indomethacin.	Also,	intravenous	administra-
tion	of	IL-1	beta	increased	urinary	sodium	excretion.	Based	
on	these	findings,	they	speculated	that	IL-6	and	IL-1	beta	play	
an	important	role	in	SIADH	development	associated	with	
inflammation.	These	findings	suggest	that	natriuresis	in	KD	
might	be	secondary	not	only	to	renal	involvement,	but	also	
cytokines,	such	as	IL-6	or	IL-1	beta.	IL-1	beta	is	also	recogniz-
ed	as	a	mediator	of	endothelial	damage	in	KD.
6)9)	Therefore,	
there	is	a	possibility	that	these	cytokines	may	involve	in	the	
pathogenesis	of	hyponatremia	due	to	SIADH,	rather	than	ce-
rebral	vasculitis	in	KD.
10)	Further	studies	are	necessary	to	elu-
cidate	the	clinical	characteristics	of	KD	patients	with	hypona-
tremia,	and	the	pathogenesis	of	hyponatremia	in	KD.
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